Optimising BH3 mimetics in B cell malignancies

Published Erin Turner on Mon, 02/27/2023 - 10:47

Monday Lunch Livestream

with Dr Mary Ann Anderson

5 December 2022

Despite significant advances in the management of patients the optimal use of BH3 mimetics remains to be fully clear.

Dr Mary Ann Anderson will explain the history and main current uses of BH3 mimetics in B cell malignancies while highlighting key areas where these agents can be optimised.

Course Details

researching reading test tubes
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Leadership and Non-Technical Skills
Speciality
Clinician
Nurse
Early to mid career researcher
Senior researcher / scientist
Monday Lunch Live
Haematology
Clinical care
Research

This course is brought to you by

Alliance members